Insider Transactions in Q1 2021 at Perrigo CO PLC (PRGO)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2021
|
Geoffrey M. Parker Director |
BUY
Open market or private purchase
|
Indirect |
2,500
+48.54%
|
$102,500
$41.29 P/Share
|
|
Mar 10
2021
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
SELL
Open market or private sale
|
Direct |
2,662
-18.5%
|
$109,142
$41.23 P/Share
|
|
Mar 08
2021
|
Svend Andersen EVP & President CHCI |
SELL
Payment of exercise price or tax liability
|
Direct |
47
-0.34%
|
$1,927
$41.82 P/Share
|
|
Mar 08
2021
|
Svend Andersen EVP & President CHCI |
BUY
Grant, award, or other acquisition
|
Direct |
5,543
+28.74%
|
$227,263
$41.82 P/Share
|
|
Mar 08
2021
|
Todd W Kingma Executive VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,166
-4.61%
|
$88,806
$41.82 P/Share
|
|
Mar 08
2021
|
Todd W Kingma Executive VP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
7,571
+13.88%
|
$310,411
$41.82 P/Share
|
|
Mar 08
2021
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,179
-8.94%
|
$48,339
$41.82 P/Share
|
|
Mar 08
2021
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
4,121
+23.81%
|
$168,961
$41.82 P/Share
|
|
Mar 08
2021
|
Grainne Quinn EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,083
-16.07%
|
$44,403
$41.82 P/Share
|
|
Mar 08
2021
|
Grainne Quinn EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,082
+23.6%
|
$85,362
$41.82 P/Share
|
|
Mar 08
2021
|
Robert Willis EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,343
-17.05%
|
$55,063
$41.82 P/Share
|
|
Mar 08
2021
|
Robert Willis EVP & CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
697
+15.05%
|
$28,577
$41.82 P/Share
|
|
Mar 08
2021
|
Robert Willis EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
1,884
+32.35%
|
$77,244
$41.82 P/Share
|
|
Mar 08
2021
|
Thomas Farrington EVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,639
-9.11%
|
$67,199
$41.82 P/Share
|
|
Mar 08
2021
|
Thomas Farrington EVP and CIO |
BUY
Grant, award, or other acquisition
|
Direct |
3,758
+17.28%
|
$154,078
$41.82 P/Share
|
|
Mar 08
2021
|
Sharon Kochan EVP & President Rx |
BUY
Grant, award, or other acquisition
|
Direct |
4,721
+11.98%
|
$193,561
$41.82 P/Share
|
|
Mar 05
2021
|
Svend Andersen EVP & President CHCI |
BUY
Payment of exercise price or tax liability
|
Direct |
55
+0.29%
|
$2,255
$41.04 P/Share
|
|
Mar 05
2021
|
Svend Andersen EVP & President CHCI |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+13.4%
|
$225,500
$41.04 P/Share
|
|
Mar 05
2021
|
Svend Andersen EVP & President CHCI |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.22%
|
$1,517
$41.04 P/Share
|
|
Mar 05
2021
|
Todd W Kingma Executive VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,444
-1.49%
|
$59,204
$41.04 P/Share
|
|
Mar 05
2021
|
Todd W Kingma Executive VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+5.36%
|
$225,500
$41.04 P/Share
|
|
Mar 05
2021
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
956
-3.35%
|
$39,196
$41.04 P/Share
|
|
Mar 05
2021
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,339
+10.47%
|
$136,899
$41.04 P/Share
|
|
Mar 05
2021
|
Grainne Quinn EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,186
-8.39%
|
$48,626
$41.04 P/Share
|
|
Mar 05
2021
|
Grainne Quinn EVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,279
+13.86%
|
$93,439
$41.04 P/Share
|
|
Mar 05
2021
|
Robert Willis EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,084
-8.61%
|
$44,444
$41.04 P/Share
|
|
Mar 05
2021
|
Robert Willis EVP & CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,083
+14.15%
|
$85,403
$41.04 P/Share
|
|
Mar 05
2021
|
James E Dillard Iii EVP & President CSCA |
SELL
Payment of exercise price or tax liability
|
Direct |
1,236
-5.93%
|
$50,676
$41.04 P/Share
|
|
Mar 05
2021
|
James E Dillard Iii EVP & President CSCA |
BUY
Exercise of conversion of derivative security
|
Direct |
4,322
+17.14%
|
$177,202
$41.04 P/Share
|
|
Mar 05
2021
|
Thomas Farrington EVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,247
-3.44%
|
$51,127
$41.04 P/Share
|
|
Mar 05
2021
|
Thomas Farrington EVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,730
+7.0%
|
$111,930
$41.04 P/Share
|
|
Mar 05
2021
|
Richard S Sorota EVP & President CSCA |
BUY
Payment of exercise price or tax liability
|
Direct |
1,108
+9.03%
|
$45,428
$41.04 P/Share
|
|
Mar 05
2021
|
Richard S Sorota EVP & President CSCA |
BUY
Exercise of conversion of derivative security
|
Direct |
2,540
+20.17%
|
$104,140
$41.04 P/Share
|
|
Mar 05
2021
|
Raymond Silcock EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,629
+36.8%
|
$148,789
$41.04 P/Share
|
|
Mar 05
2021
|
Sharon Kochan EVP & President Rx |
BUY
Exercise of conversion of derivative security
|
Direct |
4,057
+5.1%
|
$166,337
$41.04 P/Share
|
|
Mar 05
2021
|
Murray S Kessler CEO |
BUY
Payment of exercise price or tax liability
|
Direct |
5,683
+9.39%
|
$233,003
$41.04 P/Share
|
|
Mar 05
2021
|
Murray S Kessler CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,446
+25.22%
|
$1,248,286
$41.04 P/Share
|
|
Mar 05
2021
|
Murray S Kessler CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,623
-15.87%
|
$271,543
$41.04 P/Share
|
|
Feb 05
2021
|
James E Dillard Iii EVP & President CSCA |
SELL
Payment of exercise price or tax liability
|
Direct |
1,396
-15.66%
|
$60,028
$43.09 P/Share
|
|
Feb 05
2021
|
James E Dillard Iii EVP & President CSCA |
BUY
Exercise of conversion of derivative security
|
Direct |
4,297
+32.53%
|
-
|
|
Jan 06
2021
|
Richard S Sorota EVP & President CSCA |
BUY
Open market or private purchase
|
Direct |
7,513
+50.0%
|
$323,059
$43.48 P/Share
|